A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine
Clinical trial NCT03803202 · COMPLETED
Trial details
- NCT number
- NCT03803202
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2020-09-28
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.